Well thats the million dollar question. What is the likelyhood they can turn this drug into a success? Thats one for the science experts to answer. Only time will tell whether the new board is up to the job. I certainly wouldn't be panicking now, nor would I sell now if I owned shares. Considering the Board has only just been formed I would wait and see if they can turn this around. I would like to hear from the board what steps they are going to take to try to increase the efficacy level of the drug, that is obviously the key to the success of the company, unless they can gain success with the drug treating other diseases in it's present form.
CBZ Price at posting:
9.1¢ Sentiment: None Disclosure: Not Held
